AstraZeneca Executive Team Highlights Rare Disease and Bone Metabolism Strategy at ASBMR 2026 Annual Meeting

AstraZeneca PLC gathered investors, analysts, and medical professionals in Boston for a special management showcase held in conjunction with the American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting. The high-profile event, which commenced at 11:30 AM EDT on October 12, 2026, served as a vital platform for the pharmaceutical giant to outline…

Read More
Trending & Quick